Skip to main content

FDA finds control lapses at Catalent plant being sold to Novo

By Reuters  
   February 08, 2024

The FDA found quality control lapses at the Bloomington, Indiana factory of contract drug manufacturer Catalent, including discovery of a 'pest' on the manufacturing line.

Full story

Get the latest on healthcare leadership in your inbox.